BRCA2 and p53 deletions in chronic lymphocytic leukemia (CLL).

被引：0
|
作者：
Navarro, B
Chin, SF
Caldas, C
Catovsky, D
Garcia-Marco, JA
机构：
[1] Hosp Univ Puerta de Hierro, Madrid, Spain
[2] Univ Cambridge, Lab Clin Oncol, Cambridge, England
[3] Royal Marsden Hosp, Acad Dept Haematol & Cytogenet, London SW3 6JJ, England
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
925
引用
收藏
页码：226A / 226A
页数：1
相关论文
共 50 条
  • [1] Alemtuzumab for chronic lymphocytic leukemia with and without p53 deletions.
    Osuji, N
    Del Giudice, I
    Matutes, E
    Dearden, C
    Catovsky, D
    BLOOD, 2004, 104 (11) : 688A - 688A
  • [2] Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions
    Lozanski, G
    Heerema, NA
    Flinn, IW
    Smith, L
    Harbison, J
    Webb, J
    Moran, M
    Lucas, M
    Lin, T
    Hackbarth, ML
    Proffitt, JH
    Lucas, D
    Grever, MR
    Byrd, JC
    BLOOD, 2004, 103 (09) : 3278 - 3281
  • [3] Targeting p53 in chronic lymphocytic leukemia
    Moia, Riccardo
    Boggione, Paola
    Mahmoud, Abdurraouf Mokhtar
    Kodipad, Ahad Ahmed
    Adhinaveni, Ramesh
    Sagiraju, Sruthi
    Patriarca, Andrea
    Gaidano, Gianluca
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (12) : 1239 - 1250
  • [4] Autoantibodies against p53 are associated with chromosome 17p deletions in chronic lymphocytic leukemia
    Messmer, Bradley T.
    Nour-Omid, Talia S.
    Ghia, Emanuela
    Sanchez, Ana B.
    Kipps, Thomas J.
    LEUKEMIA RESEARCH, 2011, 35 (07) : 965 - 967
  • [5] p53 protein expression in chronic lymphocytic leukemia
    Sellmann, Ludger
    Carpinteiro, Alexander
    Nueckel, Holger
    Scholtysik, Rene
    Siemer, Doerte
    Klein-Hipass, Ludger
    Kube, Dieter
    Duerig, Jan
    Duehrsen, Ulrich
    Stanelle, Jens
    Kueppers, Ralf
    LEUKEMIA & LYMPHOMA, 2012, 53 (07) : 1282 - 1288
  • [6] Functional assessment of p53 in chronic lymphocytic leukemia
    Le Garff-Tavernier, M.
    Blons, H.
    Nguyen-Khac, F.
    Pannetier, M.
    Brissard, M.
    Gueguen, S.
    Jacob, F.
    Ysebaert, L.
    Susin, S. A.
    Merle-Beral, H.
    BLOOD CANCER JOURNAL, 2011, 1 : e5 - e5
  • [7] Functional assessment of p53 in chronic lymphocytic leukemia
    M Le Garff-Tavernier
    H Blons
    F Nguyen-Khac
    M Pannetier
    M Brissard
    S Gueguen
    F Jacob
    L Ysebaert
    S A Susin
    H Merle-Béral
    Blood Cancer Journal, 2011, 1 : e5 - e5
  • [8] Detection and characterisation of p53 abnormalities in chronic lymphocytic leukaemia (CLL).
    Thornton, PD
    Gruszka-Westwood, AM
    Hamoudi, R
    Atkinson, S
    Kaczmarek, P
    Morilla, R
    Matutes, E
    Catovsky, D
    BLOOD, 2001, 98 (11) : 356A - 356A
  • [9] BRCA2 and p53 work together in breast cancer
    Nasir, J
    LANCET ONCOLOGY, 2002, 3 (02): : 69 - 69
  • [10] Role of Mutant p53 in the Progression of Chronic Lymphocytic Leukemia
    Ravikrishnan, Janani
    Lai, Tzung-Huei
    Muhowski, Elizabeth
    Brinton, Lindsey
    Williams, Katie
    Thompson, Alexandria
    Blachly, James S.
    Ozer, Hatice Gulcin
    Byrd, John C.
    Lapalombella, Rosa
    Woyach, Jennifer
    Sampath, Deepa
    BLOOD, 2019, 134
12345